Literature DB >> 20592612

Surgery for renal cell carcinoma metastases.

Rodney H Breau1, Michael L Blute.   

Abstract

PURPOSE OF REVIEW: Despite the emergence of molecular targeted systemic therapy for metastatic renal cell carcinoma, cure is uncommonly achieved in the absence of surgical resection. We review the current role of metastasectomy and factors associated with outcome. RECENT
FINDINGS: Recent publication of large observational studies has better defined the expected prognosis of patients with metastatic renal cell carcinoma with or without metastasectomy. These data have highlighted prognostic factors for survival in patients treated with metastasectomy.
SUMMARY: Patients with metastatic renal cell carcinoma should be considered for multimodal therapy, including surgery. A proportion of patients will achieve long-term survival with aggressive surgical resection.

Entities:  

Mesh:

Year:  2010        PMID: 20592612     DOI: 10.1097/MOU.0b013e32833c7ada

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  15 in total

Review 1.  [Systemic and surgical management of metastatic renal cell carcinoma].

Authors:  M W Kramer; A S Merseburger; I Peters; S Waalkes; M A Kuczyk
Journal:  Urologe A       Date:  2012-02       Impact factor: 0.639

2.  Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.

Authors:  Y A M Kuijpers; R P Meijer; G N Jonges; J de Jong; J L H R Bosch; S Horenblas; A Bex
Journal:  World J Urol       Date:  2016-04-07       Impact factor: 4.226

3.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 4.  Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Authors:  Dae Y Kim; Jose A Karam; Christopher G Wood
Journal:  World J Urol       Date:  2014-04-18       Impact factor: 4.226

5.  Effect of the Nrf2-ARE signaling pathway on biological characteristics and sensitivity to sunitinib in renal cell carcinoma.

Authors:  Shiliang Ji; Yufeng Xiong; Xingxing Zhao; Yanli Liu; Li Qiang Yu
Journal:  Oncol Lett       Date:  2019-03-18       Impact factor: 2.967

6.  Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.

Authors:  Sebastien J Hotte; Anil Kapoor; Naveen S Basappa; Georg Bjarnason; Christina Canil; Henry J Conter; Piotr Czaykowski; Jeffrey Graham; Samantha Gray; Daniel Y C Heng; Pierre I Karakiewicz; Christian Kollmannsberger; Aly-Khan A Lalani; Scott A North; François Patenaude; Denis Soulières; Phillippe Violette; Eric Winquist; Lori A Wood; Shaan Dudani; Ranjena Maloni; M Neil Reaume
Journal:  Can Urol Assoc J       Date:  2019-10       Impact factor: 1.862

7.  Twelve-year survival after multiple recurrences and repeated metastasectomies for renal cell carcinoma.

Authors:  Jue Wang; Geoffrey A Talmon; Michael Feloney; Michael C Morris
Journal:  World J Surg Oncol       Date:  2011-11-28       Impact factor: 2.754

8.  p-AKT overexpression in primary renal cell carcinomas and their metastases.

Authors:  Martina Hager; Heike Haufe; Lukas Lusuardi; Nikolaus Schmeller; Christian Kolbitsch
Journal:  Clin Exp Metastasis       Date:  2010-09-16       Impact factor: 5.150

9.  Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.

Authors:  Scott A North; Naveen Basappa; Joan Basiuk; Georg Bjarnason; Rodney Breau; Christina Canil; Daniel Heng; Michael A S Jewett; Anil Kapoor; Christian Kollmannsberger; Kylea Potvin; M Neil Reaume; J Dean Ruether; Peter Venner; Lori Wood
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

10.  Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.

Authors:  M Neil Reaume; Naveen S Basappa; Lori Wood; Anil Kapoor; Georg A Bjarnason; Normand Blais; Rodney H Breau; Christina Canil; Patrick Cheung; Henry J Conter; Sebastien J Hotte; Claudio Jeldres; Michael A S Jewett; Pierre I Karakiewicz; Christian Kollmannsberger; Francois Patenaude; Alan So; Denis Soulières; Peter Venner; Phillippe Violette; Pawel Zalewski; Heather Chappell; Scott A North
Journal:  Can Urol Assoc J       Date:  2017-10       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.